Overview
To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.
Description
The purpose of the study is to evaluate the effectiveness and complications of modified deep lateral wall decompression and medial wall decompression, in order to develop a standardized technical approach to the treatment of Moderate-to-severe Grave's Ophthalmopathy.
Eligibility
Inclusion Criteria:
- EUGOGO/NOSPECS grade was moderate-to-severe thyroid associate ophthalmopathy;
- CAS≤3 score;
- stable thyroid function for at least 6 months;
- able and willing to participate in clinical trials and ensure regular follow-up;
Exclusion Criteria:
- any uncontrollable clinical problems (severe mental, neurological, cardiovascular, respiratory and other systemic diseases and malignant tumors);
- B-ultrasound or CT, MRI found other diseases causing exophthalmos (intraorbital space occupying lesion, inflammatory pseudotumor, neurofibroma, etc.);
- uveitis, glaucoma, high myopia, diabetic retinopathy and other eye diseases
- those who were considered by the researchers to be excluded